111 related articles for article (PubMed ID: 9303327)
1. The effect of glucosaminylmuramyl dipeptide injection to mice on the course of tuberculous infection and in vitro superoxide anion production.
Venkataprasad N; Ledger P; Ivanyi J
Int Arch Allergy Immunol; 1997 Sep; 114(1):23-9. PubMed ID: 9303327
[TBL] [Abstract][Full Text] [Related]
2. [Influence of liposomal glucosaminyl-muramyl dipeptide on superoxide and nitric oxide production by murine macrophages].
Parshykov OV; Stefanov OV
Ukr Biokhim Zh (1999); 2009; 81(5):74-82. PubMed ID: 20387650
[TBL] [Abstract][Full Text] [Related]
3. Glucosaminylmuramyl dipeptide-induced changes in murine macrophage metabolism.
Balitsky KP; Umansky VY; Tarakhovsky AM; Andronova TM; Ivanov VT
Int J Immunopharmacol; 1989; 11(5):429-34. PubMed ID: 2553620
[TBL] [Abstract][Full Text] [Related]
4. Evidence of differential mycobacterial growth and modulation of mycobactericidal property by glucoaminylmuramyl dipeptide in murine macrophages.
Venkataprasad N
Ann N Y Acad Sci; 1997 Dec; 832():117-29. PubMed ID: 9704041
[TBL] [Abstract][Full Text] [Related]
5. [Immunostimulating effects of muramyl dipeptide, glucosaminyl muramyl dipeptide and their synthetic derivatives in vitro].
Rakhmilevich AL; Rakhimova MS; Andronova TM; Bovin NV
Antibiot Khimioter; 1989 Aug; 34(8):586-9. PubMed ID: 2589897
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of synthetic lipid A analogs or bacterial lipopolysaccharide with glucosaminylmuramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
Shimizu T; Iwamoto Y; Yanagihara Y; Ikeda K; Achiwa K
Int J Immunopharmacol; 1992 Nov; 14(8):1415-20. PubMed ID: 1464473
[TBL] [Abstract][Full Text] [Related]
7. Study on the reduction of chemotherapy induced neutropenia in mice using glucosaminylmuramyl dipeptide.
Armstrong NA; Bolton EJ; Morris DL
Arzneimittelforschung; 1999 Aug; 49(8):716-20. PubMed ID: 10483520
[TBL] [Abstract][Full Text] [Related]
8. [Changes in purine metabolism in the macrophages of mice exposed to a new synthetic analog of muramyl dipeptide].
Umanskiĭ VIu; Tarakhovskiĭ AM; Andronova TM
Biull Eksp Biol Med; 1985 Jun; 99(6):685-7. PubMed ID: 2990603
[TBL] [Abstract][Full Text] [Related]
9. [Activation of cellular immunity in mice under normal conditions and in tumor growth during treatment with glucosaminyl muramyl dipeptide].
Pimenov AA; Rakhmilevich AL; Deev VV; Kirillova IV; Migdal TL; Andronova TM; Fuks BB
Vopr Med Khim; 1990; 36(1):58-60. PubMed ID: 2343578
[TBL] [Abstract][Full Text] [Related]
10. [Immunostimulating properties of synthetic derivatives of muramyl dipeptide and glucosaminyl muramyl dipeptide in vitro].
Rakhmilevich AL; Migdal TL; Rakhimova MS; Shneĭderova MA; Chirva VIa; Zemliakov AE
Antibiot Khimioter; 1989 Nov; 34(11):836-9. PubMed ID: 2633699
[TBL] [Abstract][Full Text] [Related]
11. [Polypeptides from murine peritoneal macrophages recognizing glycosaminylmuramoyl dipeptide].
Golovina TN; Sumaroka MV; Samokhvalova LV; Shebzukhov IuV; Makarov EA; Nesmeianov VA
Bioorg Khim; 1995 Apr; 21(4):268-74. PubMed ID: 7786317
[TBL] [Abstract][Full Text] [Related]
12. Muramylpeptides augment expression of Ia-antigens on mouse macrophages.
Nesmeyanov VA; Khaidukov SV; Komaleva RL; Andronova TM; Ivanov VT
Biomed Sci; 1990 Feb; 1(2):151-4. PubMed ID: 2102779
[TBL] [Abstract][Full Text] [Related]
13. GMDP augments antitumor action of the CP/TNFalpha combination in vivo.
Petrova EE; Simonova MA; Komaleva RL; Britsina MV; Andronova TM; Nesmeyanov VA; Valyakina TI
Biomed Pharmacother; 2010 Apr; 64(4):240-8. PubMed ID: 19932583
[TBL] [Abstract][Full Text] [Related]
14. [The action of pertussis vaccines and GMDP on the change in the enzymatic activity of macrophages from peritoneal exudate].
Ermolova EV; Britsina MV; Ozeretskovskaia MN; Shepeleva IB; Zakharova NS
Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):56-9. PubMed ID: 10876852
[TBL] [Abstract][Full Text] [Related]
15. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.
Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I
Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961
[TBL] [Abstract][Full Text] [Related]
16. Endogenous tumour necrosis factor-alpha sensitise melanoma cells to glucosaminylmuramyl dipeptide.
Valyakina TI; Komaleva RL; Petrova EE; Malakhov AA; Shamborant OG; Andronova TM; Nesmeyanov VA
FEBS Lett; 1998 Apr; 426(3):373-6. PubMed ID: 9600269
[TBL] [Abstract][Full Text] [Related]
17. Glucosaminylmuramyl dipeptide (GMDP) modulates endothelial cell activities in vitro but has no effect on angiogenesis in vivo.
Li CG; Kumar S; Ledger PW; Ponting JM; Carette M; Allan E
Inflamm Res; 1997 Sep; 46(9):348-53. PubMed ID: 9339390
[TBL] [Abstract][Full Text] [Related]
18. Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma.
Edwards CK; Hedegaard HB; Zlotnik A; Gangadharam PR; Johnston RB; Pabst MJ
J Immunol; 1986 Mar; 136(5):1820-7. PubMed ID: 3005400
[TBL] [Abstract][Full Text] [Related]
19. [Structure-functional study of glycosaminylmuramoyl peptides. The effect of chemical modification of N-acetylglucosaminyl-N-acetylmuramoyldipeptide on its immunomodulating properties in vivo and in vitro].
Meshcheriakova EA; Gur'ianova SV; Makarov EA; Andronova TM; Ivanov VT
Bioorg Khim; 1991 Sep; 17(9):1157-65. PubMed ID: 1807252
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of glucosaminylmuramyldipeptide binding sites of murine macrophages.
Golovina TN; Sumaroka MV; Samokhvalova LV; Shebzukhov YuV ; Andronova TM; Nesmeyanov VA
FEBS Lett; 1994 Dec; 356(1):9-12. PubMed ID: 7988729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
